All‐oral direct‐acting antiviral therapy against hepatitis C virus (HCV) in human immunodeficiency virus/HCV–coinfected subjects in real‐world practiceJuan Berenguer, Juan González‐García, Pablo Ryan et al.|Hepatology|2018Cited by 79
Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort studySergio Serrano‐Villar, Ignacio de los Santos, Federico Pulido et al.|The Lancet HIV|2020Cited by 70
Reinfection by hepatitis C virus following effective all-oral direct-acting antiviral drug therapy in HIV/hepatitis C virus coinfected individualsJuan Berenguer, Juan González‐García, Lourdes Domínguez et al.|AIDS|2018Cited by 58
Expanding HIV clinical monitoring: the role of CD4, CD8, and CD4/CD8 ratio in predicting non-AIDS eventsJavier Martínez‐Sanz, M. Mar Alonso, Rebeca Izquierdo et al.|EBioMedicine|2023Cited by 40
Life expectancy of people with HIV on antiretroviral therapy in SpainInmaculada Jarrín, Ana Koerting, Antonio Rivero et al.|AIDS|2023Cited by 24